Search by Drug Name or NDC

    NDC 43068-0304-02 Hetlioz 4 mg/mL Details

    Hetlioz 4 mg/mL

    Hetlioz is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Vanda Pharmaceuticals Inc.. The primary component is TASIMELTEON.

    Product Information

    NDC 43068-0304
    Product ID 43068-304_3248eef5-6bad-4844-a6f9-2f5fddd39c8d
    Associated GPIs 60250070001820
    GCN Sequence Number 081738
    GCN Sequence Number Description tasimelteon ORAL SUSP 4 MG/ML ORAL
    HIC3 H8B
    HIC3 Description HYPNOTICS, MELATONIN MT1/MT2 RECEPTOR AGONISTS
    GCN 48937
    HICL Sequence Number 040927
    HICL Sequence Number Description TASIMELTEON
    Brand/Generic Brand
    Proprietary Name Hetlioz
    Proprietary Name Suffix LQ
    Non-Proprietary Name tasimelteon
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 4
    Active Ingredient Units mg/mL
    Substance Name TASIMELTEON
    Labeler Name Vanda Pharmaceuticals Inc.
    Pharmaceutical Class Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA214517
    Listing Certified Through 2024-12-31

    Package

    NDC 43068-0304-02 (43068030402)

    NDC Package Code 43068-304-02
    Billing NDC 43068030402
    Package 1 BOTTLE in 1 CARTON (43068-304-02) / 48 mL in 1 BOTTLE
    Marketing Start Date 2020-12-10
    NDC Exclude Flag N
    Pricing Information N/A